Return to warmwell.com
Extract from http://www.oie.int/eng/normes/mcode/en_chapitre_1.8.5.htm

Article 8.5.8.


 

Recovery of free status

  1. When an FMD outbreak or FMDV infection occurs in an FMD free country or zone where vaccination is not practised, one of the following waiting periods is required to regain the status of FMD free country or zone where vaccination is not practised:

    1. 3 months after the last case where a stamping-out policy and serological surveillance are applied in accordance with Articles 8.5.40. to 8.5.46.; or

    2. 3 months after the slaughter of all vaccinated animals where a stamping-out policy, emergency vaccination and serological surveillance are applied in accordance with Articles 8.5.40. to 8.5.46.; or

    3. 6 months after the last case or the last vaccination (according to the event that occurs the latest), where a stamping-out policy, emergency vaccination not followed by the slaughtering of all vaccinated animals, and serological surveillance are applied in accordance with Articles 8.5.40. to 8.5.46., provided that a serological survey based on the detection of antibodies to nonstructural proteins of FMDV demonstrates the absence of infection in the remaining vaccinated population.

    Where a stamping-out policy is not practised, the above waiting periods do not apply, and Article 8.5.2. or 8.5.4. applies.

  2. When an FMD outbreak or FMDV infection occurs in an FMD free country or zone where vaccination is practised, one of the following waiting periods is required to regain the status of FMD free country or zone where vaccination is practised:

    1. 6 months after the last case where a stamping-out policy, emergency vaccination and serological surveillance in accordance with Articles 8.5.40. to 8.5.46. are applied, provided that the serological surveillance based on the detection of antibodies to nonstructural proteins of FMDV demonstrates the absence of virus circulation; or

    2. 18 months after the last case where a stamping-out policy is not applied, but emergency vaccination and serological surveillance in accordance with Articles 8.5.40. to 8.5.46. are applied, provided that the serological surveillance based on the detection of antibodies to nonstructural proteins of FMDV demonstrates the absence of virus circulation.

return to warmwell.com